| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nuvectis Pharma, Inc. (NVCT) has 7 insiders with recent SEC Form 4 filings, including 17 buys and 0 sells. NVCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.68M | $71.94M | - | |
| 10% | 3.14M | $61.38M | - | |
| Other | 1.81M | $35.35M | - | |
| Other | 1.79M | $35.09M | - | |
| VP | 200.1K | $3.92M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 750 | $7.23 | $5,425.00 | - | +38.2% | +13.4% | |
| Nov 17, 2022 | Shemesh Shay72 | Chief Dev. &Ops. Officer | Buy | 300 | $7.15 | $2,145.00 | - | +43.7% | +13.9% | |
| Nov 10, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 1,000 | $7.07 | $7,070.00 | - | +56.1% | +14.2% | |
| Sep 30, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 1,000 | $7.35 | $7,345.00 | - | +4.7% | +81.8% | |
| Sep 26, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 1,500 | $7.85 | $11,775.00 | - | -4.8% | +77.8% | |
| Sep 23, 2022 | Shemesh Shay72 | Chief Dev. &Ops. Officer | Buy | 220 | $7.87 | $1,731.40 | - | -6.1% | +77.1% | |
| Sep 2, 2022 | Shemesh Shay72 | Chief Dev. &Ops. Officer | Buy | 404 | $8.31 | $3,357.24 | - | -8.4% | +78.5% | |
| Sep 2, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 1,700 | $8.29 | $14,099.00 | - | -8.4% | +78.5% | |
| Sep 1, 2022 | Shemesh Shay72 | Chief Dev. &Ops. Officer | Buy | 3,006 | $8.07 | $24,258.42 | +0.1% | -9.4% | +82.5% | |
| Aug 29, 2022 | Bentsur Ron64 | Chairman &CEO | Buy | 1,500 | $9.05 | $13,570.00 | - | -16.6% | +70.9% |